Donafenib plus hepatic arterial infusion chemotherapy and anti-PD-1 antibody therapies for unresectable hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e16172
Abstract: e16172 Background: Donafenib showed promising efficacy and safety in advanced hepatocellular carcinoma (HCC). But the efficacy of Donafenib plus hepatic arterial infusion chemotherapy (HAIC) and anti-PD-1 antibody (aPD1) therapies remained unknown. This study aimed to… read more here.
Keywords: donafenib; hepatic arterial; plus hepatic; arterial infusion ... See more keywords